Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus
Uterine cancer, according to the latest data from the 2017 Croatian Cancer Registry, is the fourth most common cancer in women in Croatia and ranking eighth in mortality. Most commonly, it is diagnosed in postmenopausal women at the age 50–79. Endometrial cancer diagnosis is determined by pathohisto...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hrvatski liječnički zbor
2021-12-01
|
Series: | Liječnički vjesnik |
Subjects: | |
Online Access: | http://lijecnicki-vjesnik.hlz.hr/pdf/11-12-2021/02_frobe.pdf |
_version_ | 1818940431872819200 |
---|---|
author | Ana Fröbe Blanka Jakšić Višnja Matković Herman Haller Branka Petrić Miše Dražan Butorac Goran Vujić Marina Kos Tihana Boraska Jelavić Snježana Tomić Vanda Paradžik Pašalić Ante Ćorušić Ani Mihaljević Ferari Ivana Canjko Angela Prgomet Sečan Danijela Vrdoljak Mozetić Tanja Leniček Gordana Lovrenčić-Prpić Anastazija Aleksandrova Stanojević Eduard Vrdoljak |
author_facet | Ana Fröbe Blanka Jakšić Višnja Matković Herman Haller Branka Petrić Miše Dražan Butorac Goran Vujić Marina Kos Tihana Boraska Jelavić Snježana Tomić Vanda Paradžik Pašalić Ante Ćorušić Ani Mihaljević Ferari Ivana Canjko Angela Prgomet Sečan Danijela Vrdoljak Mozetić Tanja Leniček Gordana Lovrenčić-Prpić Anastazija Aleksandrova Stanojević Eduard Vrdoljak |
author_sort | Ana Fröbe |
collection | DOAJ |
description | Uterine cancer, according to the latest data from the 2017 Croatian Cancer Registry, is the fourth most common cancer in women in Croatia and ranking eighth in mortality. Most commonly, it is diagnosed in postmenopausal women at the age 50–79. Endometrial cancer diagnosis is determined by pathohistological analysis of curettage or biopsy and the stage of the disease by radiological imaging. In most patients, the disease is diagnosed in the localized stage and is successfully treated surgically; depending on the pathohistological finding, appropriate adjuvant therapy could be applied. Locally advanced disease is most commonly treated surgically with adjuvant therapy, and metastatic with chemotherapy or hormone therapy. Mesenchymal tumors of the uterine body are treated surgically with the addition of systemic adjuvant therapy, or only systemic therapy in the case of metastatic disease. The following manuscript presents clinical guidelines to standardise procedures for the diagnosis, treatment and follow-up of patients with malignant tumors of the uterus in the Republic of Croatia. |
first_indexed | 2024-12-20T06:39:32Z |
format | Article |
id | doaj.art-f76edb87605b4e399cbea9ffc01535c6 |
institution | Directory Open Access Journal |
issn | 0024-3477 1849-2177 |
language | English |
last_indexed | 2024-12-20T06:39:32Z |
publishDate | 2021-12-01 |
publisher | Hrvatski liječnički zbor |
record_format | Article |
series | Liječnički vjesnik |
spelling | doaj.art-f76edb87605b4e399cbea9ffc01535c62022-12-21T19:49:54ZengHrvatski liječnički zborLiječnički vjesnik0024-34771849-21772021-12-0114311-1240441510.26800/LV-143-11-12-2Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpusAna Fröbe0Blanka JakšićVišnja MatkovićHerman HallerBranka Petrić MišeDražan ButoracGoran VujićMarina KosTihana Boraska JelavićSnježana TomićVanda Paradžik PašalićAnte ĆorušićAni Mihaljević FerariIvana CanjkoAngela Prgomet SečanDanijela Vrdoljak MozetićTanja LeničekGordana Lovrenčić-PrpićAnastazija Aleksandrova StanojevićEduard VrdoljakKlinika za onkologiju i nuklearnu medicinu, Klinički bolnički centar Sestre milosrdnice, ZagrebUterine cancer, according to the latest data from the 2017 Croatian Cancer Registry, is the fourth most common cancer in women in Croatia and ranking eighth in mortality. Most commonly, it is diagnosed in postmenopausal women at the age 50–79. Endometrial cancer diagnosis is determined by pathohistological analysis of curettage or biopsy and the stage of the disease by radiological imaging. In most patients, the disease is diagnosed in the localized stage and is successfully treated surgically; depending on the pathohistological finding, appropriate adjuvant therapy could be applied. Locally advanced disease is most commonly treated surgically with adjuvant therapy, and metastatic with chemotherapy or hormone therapy. Mesenchymal tumors of the uterine body are treated surgically with the addition of systemic adjuvant therapy, or only systemic therapy in the case of metastatic disease. The following manuscript presents clinical guidelines to standardise procedures for the diagnosis, treatment and follow-up of patients with malignant tumors of the uterus in the Republic of Croatia.http://lijecnicki-vjesnik.hlz.hr/pdf/11-12-2021/02_frobe.pdfendometrial neoplasms – diagnosispathologytherapy; sarcoma – diagnosistherapy; sarcomaendometrial stromal – diagnosistherapy; uterine neoplasms – diagnosis |
spellingShingle | Ana Fröbe Blanka Jakšić Višnja Matković Herman Haller Branka Petrić Miše Dražan Butorac Goran Vujić Marina Kos Tihana Boraska Jelavić Snježana Tomić Vanda Paradžik Pašalić Ante Ćorušić Ani Mihaljević Ferari Ivana Canjko Angela Prgomet Sečan Danijela Vrdoljak Mozetić Tanja Leniček Gordana Lovrenčić-Prpić Anastazija Aleksandrova Stanojević Eduard Vrdoljak Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus Liječnički vjesnik endometrial neoplasms – diagnosis pathology therapy; sarcoma – diagnosis therapy; sarcoma endometrial stromal – diagnosis therapy; uterine neoplasms – diagnosis |
title | Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus |
title_full | Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus |
title_fullStr | Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus |
title_full_unstemmed | Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus |
title_short | Clinical guidelines for diagnosis, treatment and monitoring of patients with malignant tumors of uterine corpus |
title_sort | clinical guidelines for diagnosis treatment and monitoring of patients with malignant tumors of uterine corpus |
topic | endometrial neoplasms – diagnosis pathology therapy; sarcoma – diagnosis therapy; sarcoma endometrial stromal – diagnosis therapy; uterine neoplasms – diagnosis |
url | http://lijecnicki-vjesnik.hlz.hr/pdf/11-12-2021/02_frobe.pdf |
work_keys_str_mv | AT anafrobe clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT blankajaksic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT visnjamatkovic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT hermanhaller clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT brankapetricmise clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT drazanbutorac clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT goranvujic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT marinakos clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT tihanaboraskajelavic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT snjezanatomic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT vandaparadzikpasalic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT antecorusic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT animihaljevicferari clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT ivanacanjko clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT angelaprgometsecan clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT danijelavrdoljakmozetic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT tanjalenicek clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT gordanalovrencicprpic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT anastazijaaleksandrovastanojevic clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus AT eduardvrdoljak clinicalguidelinesfordiagnosistreatmentandmonitoringofpatientswithmalignanttumorsofuterinecorpus |